Naveris Is A Biotechnology Company Based In Walthammawith An Additional Office In Durhamncthe Company Specializes In Developing Innovative Liquid Biopsy Technologies Aimed At Early Cancer Detection And Monitoringnaveris Focuses On Improving Patient Outcomes Through Highly Sensitive Blood Tests That Can Identify Viral Driven Cancers Earlier Than Traditional Methods The Flagship Productnavdxa Is A Clinically Validated Blood Test That Detects Tumor Tissue Modified Hpv Dnattmvaspecifically For Hpv Driven Cancersit Is Particularly Effective In Monitoring Recurrence In Head And Neck Cancer Patientsdemonstrating A 91Detection Rate Of Recurrence Before Imaging Confirmationnaveris Also Utilizes A Proprietary Platform To Analyze Circulating Tumor Dnactdna Enhancing Sensitivity For Early Diagnosistreatment Response Monitoringand Recurrence Detection The Company Targets Asymptomatic Populations For Early Detectionpatients Undergoing Treatment For Real Time Monitoringand Individuals In Remission For Surveillance Of Recurrencenaveris Is Committed To Delivering Advanced Diagnostic Technologies To Transform Cancer Care And Improve Detection Timelines
No conferences found for this company.
| Company Name | Naveris Inc |
| Country |
United States
|
| Address | N/A |
| Telephone | N/A |
| N/A |
